| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 8291 |
| 1 | ERENUMAB-AOOE | 7197 |
| 2 | ETANERCEPT | 5264 |
| 3 | PEGFILGRASTIM | 3839 |
| 4 | SECUKINUMAB | 1210 |
| 5 | GUSELKUMAB | 1155 |
| 6 | DENOSUMAB | 1038 |
| 7 | GOLIMUMAB | 1035 |
| 8 | EPINEPHRINE | 875 |
| 9 | USTEKINUMAB | 814 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1% | 4 | 0.3077 |
| 1 | ERENUMAB-AOOE | 7197 | 0.1946 |
| 2 | VALRUBICIN | 23 | 0.1369 |
| 3 | GUSELKUMAB | 1155 | 0.0937 |
| 4 | LIDOCAINE PATCH 4% | 5 | 0.0909 |
| 5 | EVOLOCUMAB | 8291 | 0.0884 |
| 6 | FREMANEZUMAB-VFRM | 451 | 0.0878 |
| 7 | NITROGEN | 6 | 0.0870 |
| 8 | AVOBENZONE 3%, HOMOSALATE 10%, OCTISALATE 5%, OCTOCRYLENE 5% | 7 | 0.0795 |
| 9 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | 15 | 0.0781 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 8312 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 6392 |
| 2 | Leukocyte Growth Factor [EPC] | 3889 |
| 3 | Interleukin-23 Antagonist [EPC] | 1972 |
| 4 | Interleukin-17A Antagonist [EPC] | 1228 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1126 |
| 6 | RANK Ligand Inhibitor [EPC] | 1038 |
| 7 | Catecholamine [EPC] | 880 |
| 8 | alpha-Adrenergic Agonist [EPC] | 877 |
| 9 | beta-Adrenergic Agonist [EPC] | 877 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Inhalation Diagnostic Agent [EPC] | 1 | 0.1250 |
| 1 | PCSK9 Inhibitor [EPC] | 8312 | 0.0735 |
| 2 | Leukocyte Growth Factor [EPC] | 3889 | 0.0357 |
| 3 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 41 | 0.0292 |
| 4 | Oxaborole Antifungal [EPC] | 20 | 0.0270 |
| 5 | Interleukin-23 Antagonist [EPC] | 1972 | 0.0212 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 326 | 0.0191 |
| 7 | alpha-Adrenergic Agonist [EPC] | 877 | 0.0190 |
| 8 | Interleukin-5 Antagonist [EPC] | 446 | 0.0178 |
| 9 | Catecholamine [EPC] | 880 | 0.0167 |